BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) today announced the appointment of James J. Egan as Chief Operating Officer, Sucampo Pharmaceuticals, Inc., a newly-created position, effective September 15, 2009, reporting to Ryuji Ueno, M.D., Ph.D., Ph.D., Chair, and Chief Executive Officer of Sucampo Pharmaceuticals, Inc.
